Govt plan to Regulate the sale Of Fairness Creams Containing Steroids

After analyzing the side effects of the steroids on the skin, the health ministry planned to regulate the over-the-counter sale of fairness creams carrying corticosteroids. Corticosteroids is a steroid hormone is known to damage skin damage and other health hazards.

Willingness to get Fair skin, and obsession with fairness will going to face a regulatory crackdown as no one can purchase creams without prescriptions.  To improve the effectiveness of lightening skin, some fairness cream manufacturers add corticosteroids, but these are very dangerous to the skin.

According to skin specialists, it is impossible to filter how many companies use steroids as producers not mentioned on their packs, in breach of labeling rules. Dermatologists said these creams not come under schedule H drugs, simply means anyone can buy over the counter and used without any prescription.

According to the talks, A notification will be released soon and the government has proposed amendments to the Drugs and Cosmetic Rules, 1945 inserting potent corticosteroid ingredients in Schedule H, which would restrict the over-the-counter sale of these topical creams.

Dermatologists experienced there is a link between these creams and cases of Topical Steroid Damaged Face (TSDF)’ s type of skin damage due to the steroid used in creams. Due to wide-spread of steroids, it becomes hard to treat simple skin ailments. There is a huge increase in the number of patients who are experiencing the side-effects of steroid use.

And it is recommended by the drug technical body-Drugs Technical Advisory Board to insert steroid-laced fairness cream in schedule H.

Related Posts

Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

HC denies bail to pharma company owner for manufacturing spurious drugs

Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda